[
  {
    "patient_ID": "TCGA.3B.A9HI",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 850,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 959,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HI",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 850,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 959,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HI",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 983,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1262,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HI",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 983,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1262,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HI",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1493,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HL",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 185,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 215,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HL",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 447,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 481,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HL",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 229,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 432,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HL",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 229,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 432,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HL",
    "drug_therapy_name": "PAZOPANIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 532,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 542,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HP",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 595,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 616,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HP",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 595,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 616,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HR",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1019,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1088,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HR",
    "drug_therapy_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1019,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1088,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HR",
    "drug_therapy_name": "TRABECTEDIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1425,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1621,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HR",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1758,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2096,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.3B.A9HR",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2117,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2396,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HR",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2117,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2396,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HR",
    "drug_therapy_name": "PAZOPANIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2396,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2683,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HS",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 568,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 592,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HS",
    "drug_therapy_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 568,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 592,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HS",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1034,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1132,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HS",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1034,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1132,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HS",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1202,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1243,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HT",
    "drug_therapy_name": "CISPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 103,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HV",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 271,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HV",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 270,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HV",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 339,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 369,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HV",
    "drug_therapy_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 339,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 369,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HZ",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 482,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 602,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HZ",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 482,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 602,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HZ",
    "drug_therapy_name": "PAZOPANIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 834,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 889,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HZ",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 906,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1164,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9HZ",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 906,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1164,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9I0",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 580,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 706,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.3B.A9I0",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 948,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1054,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9I0",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 941,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1054,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9I1",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 176,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9I1",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 36,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9I1",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 332,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 388,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3B.A9I1",
    "drug_therapy_name": "LETROZOLE",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 437,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 500,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A3LU",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 451,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 492,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A3LU",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 451,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 492,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A3LU",
    "drug_therapy_name": "PD 0332991",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1974,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2200,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DX.A3U6",
    "drug_therapy_name": "PD 0332991",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 484,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 540,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DX.A3U6",
    "drug_therapy_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 554,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 966,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A3U7",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 350,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 549,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A3U7",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 350,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 606,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A3U7",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 741,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 922,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A3U7",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 741,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 922,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A3U7",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 942,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 945,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A3U7",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 969,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1126,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A3U7",
    "drug_therapy_name": "PAZOPANIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1133,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1182,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A3U7",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1258,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1301,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A3U7",
    "drug_therapy_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1352,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1427,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A3UC",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 629,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 709,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A3UC",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1045,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1119,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A3UC",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1045,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1119,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A3UC",
    "drug_therapy_name": "PAZOPANIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1144,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1287,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A3UC",
    "drug_therapy_name": "TRABECTEDIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1308,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1329,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A3UC",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1675,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1675,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A3UF",
    "drug_therapy_name": "MORAB-004",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1802,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1915,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DX.A3UF",
    "drug_therapy_name": "MLN8237",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1938,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1945,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DX.A6B7",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 86,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A6B7",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 72,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A6B8",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 255,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A6BA",
    "drug_therapy_name": "PAZOPANIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1493,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A6BA",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 705,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 867,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A6BA",
    "drug_therapy_name": "EVEROLIMUS",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 525,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 567,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DX.A6BA",
    "drug_therapy_name": "R1507",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 525,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 567,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DX.A6BA",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 446,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 507,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A6BG",
    "drug_therapy_name": "PD 0332991",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 161,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 191,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DX.A6BG",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 198,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A6BG",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 198,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A6YX",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 285,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 407,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A6YX",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 292,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 407,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A6YX",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 444,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 484,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A7EI",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 990,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 991,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A7EN",
    "drug_therapy_name": "PAZOPANIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 352,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A7EN",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 216,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A7EN",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 216,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A7EQ",
    "drug_therapy_name": "VORINOSTAT",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 791,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 830,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A7EQ",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 559,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 675,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A7EQ",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 559,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 675,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A7EQ",
    "drug_therapy_name": "CISPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 451,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 508,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A7EQ",
    "drug_therapy_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 403,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 424,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A7EQ",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 293,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 349,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A8BH",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 280,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A8BT",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 697,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 773,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A8BT",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 697,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 773,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A8BU",
    "drug_therapy_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1080,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1081,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A8BU",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 678,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1035,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A8BU",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 678,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1035,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A8BU",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 590,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 647,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A8BU",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 228,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A8BU",
    "drug_therapy_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 228,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A8BV",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 750,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 903,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A8BV",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 750,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 903,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A8BV",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 415,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 446,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.A8BV",
    "drug_therapy_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 415,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 446,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.AB2E",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 133,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 222,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.AB2E",
    "drug_therapy_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 133,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 222,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.AB2E",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 253,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.AB3B",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 158,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 269,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.AB3B",
    "drug_therapy_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 158,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 269,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.AB3C",
    "drug_therapy_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 181,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.AB3C",
    "drug_therapy_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 181,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DX.AB3C",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 89,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FX.A3RE",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 136,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FX.A48G",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 168,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FX.A48G",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 168,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FX.A48G",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 174,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 289,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FX.A48G",
    "drug_therapy_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 309,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 414,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FX.A48G",
    "drug_therapy_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 503,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 593,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FX.A8OO",
    "drug_therapy_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 243,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HB.A3L4",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 431,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 473,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_dose": 50,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.HB.A3L4",
    "drug_therapy_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 734,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 945,
    "drug_cycles": 11,
    "drug_units": "G/DAY",
    "drug_dose": 2.8,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.HB.A3L4",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 216,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.HB.A3L4",
    "drug_therapy_name": "LETROZOLE",
    "pharmaceutical_therapy_type.1": "HORMONE THERAPY",
    "days_to_drug_start": 582,
    "pharmaceutical_tx_ongoing": true,
    "drug_units": "MG/DAY",
    "drug_dose": 2.5,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.HB.A3L4",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 216,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_dose": 900,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.HB.A43Z",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 105,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HB.A43Z",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 105,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HB.A43Z",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 189,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HS.A5N9",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 91,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HS.A5N9",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 91,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.IE.A3OV",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.IE.A3OV",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.IE.A3OV",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 778,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 836,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.IE.A3OV",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 787,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 836,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.IE.A3OV",
    "drug_therapy_name": "TRABECTEDIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1411,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1594,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.IE.A3OV",
    "drug_therapy_name": "AP-23573 (ARIAD)",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1609,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1660,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.IE.A3OV",
    "drug_therapy_name": "EZN-2968",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1834,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1918,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.IE.A3OV",
    "drug_therapy_name": "ENOTICUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 1973,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2037,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.IE.A3OV",
    "drug_therapy_name": "THRESHOLD-302",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2073,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2093,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.IE.A3OV",
    "drug_therapy_name": "PEMETREXED",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2232,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2293,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.IE.A4EH",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 326,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 448,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "patient_ID": "TCGA.IE.A4EH",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 326,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 448,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "patient_ID": "TCGA.IE.A6BZ",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 204,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "patient_ID": "TCGA.IE.A6BZ",
    "drug_therapy_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 204,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "patient_ID": "TCGA.IE.A6BZ",
    "drug_therapy_name": "MESNA",
    "pharmaceutical_therapy_type.1": "ANCILLARY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 204,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "patient_ID": "TCGA.IF.A3RQ",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 441,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 457,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.IF.A4AJ",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 567,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 600,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.IS.A3K7",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 238,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.IS.A3KA",
    "drug_therapy_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type.1": "HORMONE THERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 187,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.IS.A3KA",
    "drug_therapy_name": "MEGESTROL ACETATE",
    "pharmaceutical_therapy_type.1": "HORMONE THERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 187,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.IW.A3M4",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 170,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.IW.A3M4",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 170,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.IW.A3M5",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 154,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 154,
    "drug_cycles": 1,
    "drug_units": "G/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 80,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 384000
  },
  {
    "patient_ID": "TCGA.IW.A3M5",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 147,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 170,
    "drug_cycles": 3,
    "drug_units": "G/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 675,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3240000
  },
  {
    "patient_ID": "TCGA.IW.A3M6",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 45,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.IW.A3M6",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 45,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.JV.A5VE",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 165,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.JV.A5VE",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 165,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.JV.A75J",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.JV.A75J",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.K1.A3PN",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 121,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 182,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.K1.A3PN",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 151,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 182,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.K1.A42X",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2134,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2293,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.K1.A42X",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 3256,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3417,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.K1.A6RT",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 275,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.K1.A6RU",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 143,
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KD.A5QS",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 72,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KD.A5QS",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "HORMONE THERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 72,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KD.A5QS",
    "drug_therapy_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 366,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 876,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KD.A5QS",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 366,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 471,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KD.A5QS",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 499,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 876,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KD.A5QU",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 219,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KD.A5QU",
    "drug_therapy_name": "CISPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 219,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KF.A41W",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 137,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.LI.A67I",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 595,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 670,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.MB.A5Y8",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 248,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.MB.A5Y8",
    "drug_therapy_name": "IFOSFAMIDE",
    "days_to_drug_start": 248,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.MO.A47P",
    "drug_therapy_name": "DOXORUBICIN",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 227,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.PT.A8TR",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 155,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.PT.A8TR",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 155,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.QQ.A5VB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing": false
  },
  {
    "patient_ID": "TCGA.QQ.A8VD",
    "drug_therapy_name": "SULINDAC",
    "pharmaceutical_therapy_type.1": "ANCILLARY",
    "days_to_drug_start": 529,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1499,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QQ.A8VD",
    "drug_therapy_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type.1": "HORMONE THERAPY",
    "days_to_drug_start": 613,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1499,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QQ.A8VD",
    "drug_therapy_name": "IMATINIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2094,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2780,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QQ.A8VD",
    "drug_therapy_name": "RALOXIFENE",
    "pharmaceutical_therapy_type.1": "HORMONE THERAPY",
    "days_to_drug_start": 2807,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2886,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QQ.A8VD",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2898,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3026,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QQ.A8VD",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 3939,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.RN.AAAQ",
    "drug_therapy_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 89,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.RN.AAAQ",
    "drug_therapy_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 362,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 392,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.RN.AAAQ",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 392,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 453,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.RN.AAAQ",
    "drug_therapy_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 392,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 453,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.SG.A6Z4",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 228,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.SI.A71O",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 350,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 462,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.SI.A71O",
    "drug_therapy_name": "EVEROLIMUS",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 350,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 462,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.SI.A71O",
    "drug_therapy_name": "TIVOZANIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 489,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 545,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.SI.A71P",
    "drug_therapy_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 174,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 269,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.X2.A95T",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 132,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.X2.A95T",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 132,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.X6.A7WC",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 819,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 854,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.X6.A8C2",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 677,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.X6.A8C4",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 156,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.X6.A8C4",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 327,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 504,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.X6.A8C4",
    "drug_therapy_name": "TRABECTEDIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 511,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.X6.A8C4",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 327,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 504,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.X6.A8C4",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 327,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 504,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.X6.A8C4",
    "drug_therapy_name": "VALPROIC ACID",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 327,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 504,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.X6.A8C6",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 785,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 840,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.X6.A8C6",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 911,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 966,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.X9.A971",
    "drug_therapy_name": "DOCETAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 413,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 434,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.X9.A971",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 413,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 434,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.X9.A973",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 323,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 392,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.X9.A973",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 323,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 392,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.X9.A973",
    "drug_therapy_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 323,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 392,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  }
]
